Alamar HoldCo reports 3.23M Attovia shares on Form 3

Alamar HoldCo, LLC reported its initial beneficial ownership in Attovia Therapeutics, Inc. as a more than 10% holder on Form 3.

Accepted by SEC EDGAR 08/05/2026 - 07:19 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Alamar HoldCo, LLC reported its initial beneficial ownership in Attovia Therapeutics, Inc. as a more than 10% holder on Form 3. The entity holds 3,229,278 shares of Common Stock directly. The remarks state that, in connection with the closing of Attovia’s initial public offering, Alamar HoldCo will cease to be a 10% holder.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Alamar HoldCo, LLC

Role 10% Owner

Type	Security	Shares	Price	Value
Holding	Common Stock	--	--	--

Holdings: Common Stock — 3,229,278 shares (Direct)

Key Figures

Common Stock held: 3,229,278 shares Holder status: More than 10% holder Form type: Form 3

3 metrics

Common Stock held 3,229,278 shares Shares of Attovia Common Stock beneficially owned by Alamar HoldCo, LLC following the reported position

Holder status More than 10% holder Reporting person status triggering Form 3 filing requirements

Form type Form 3 Initial statement of beneficial ownership of Attovia equity securities

Key Terms

beneficial ownership, 10% holder, initial public offering

3 terms

beneficial ownership financial

"reported its initial beneficial ownership in Attovia Therapeutics, Inc."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

10% holder regulatory

"the Reporting Entity will cease to be a 10% holder."

initial public offering financial

"In connection with the closing of the Issuer's initial public offering"

An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Attovia Therapeutics (ATTO) report in this Form 3 filing?

The filing shows Alamar HoldCo, LLC as a more than 10% beneficial owner of Attovia, holding 3,229,278 Common Stock shares. It is an initial statement of ownership, not a report of new share purchases or sales.

How many Attovia (ATTO) shares does Alamar HoldCo, LLC report owning?

Alamar HoldCo, LLC reports beneficial ownership of 3,229,278 shares of Common Stock. This figure represents its direct holdings following the reported position and is the basis for its status as a more than 10% holder before the IPO-related change.

Will Alamar HoldCo, LLC remain a 10% holder of Attovia (ATTO) after the IPO?

The remarks state that, in connection with closing Attovia’s initial public offering, Alamar HoldCo, LLC will cease to be a 10% holder. The filing does not detail the mechanics, only that its ownership percentage will fall below the 10% threshold.

Does this Attovia (ATTO) Form 3 show any insider buying or selling?

No. The Form 3 presents holdings of 3,229,278 Common Stock shares by Alamar HoldCo, LLC but does not report any share purchases, sales, or option exercises. It is a snapshot of ownership, not a transaction report.

Who is identified as the reporting person in Attovia (ATTO)’s Form 3?

The reporting person is Alamar HoldCo, LLC, identified as a more than 10% owner and not as a director or officer. The ownership is reported as direct, meaning the LLC itself holds the disclosed Common Stock shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Alamar HoldCo, LLC

(Last) (First) (Middle)

47071 BAYSIDE PARKWAY

(Street)

FREMONT CALIFORNIA 94538

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/04/2026

3. Issuer Name and Ticker or Trading Symbol
Attovia Therapeutics, Inc. [ ATTO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	3,229,278	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

In connection with the closing of the Issuer's initial public offering, the Reporting Entity will cease to be a 10% holder.

	Yuling Luo, President	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)